Shares in Germany’s Bayer plunge on US weed killer ruling

FAN Editor

Shares in Germany’s Bayer have plunged after a U.S. jury found the Roundup weed killer was a substantial factor in a California man’s cancer — the second case that has gone against manufacturer Monsanto, acquired by Bayer last year.

Continue Reading Below

Bayer AG shares dropped 13 percent to 60.66 euros ($68.84) in Frankfurt Wednesday. On Tuesday, a federal court jury in San Francisco ruled unanimously in a lawsuit against Monsanto. Attorneys say the trial, which will determine in a second phase whether the company is liable and if so, for how much, could help determine the fate of hundreds of similar lawsuits.

Monsanto says studies have established that Roundup’s active ingredient, glyphosate, is safe. It has appealed a separate U.S. court decision last year in favor of a man who used Roundup.

Free America Network Articles

Leave a Reply

Next Post

Joe Biden inches closer to 2020 run with calls to donors

Former Vice President Joe Biden is inching closer to a run for the White House. CBS News has learned that he’s started to tell potential donors about his plans for the 2020 presidential election. After nearly accidentally announcing his plans in a weekend speech, several people familiar with his plans […]